Ut wisi enim ad minim veniam, quis laore nostrud exerci tation ulm hedi corper turet suscipit lobortis nisl ut

Recent Posts

    Sorry, no posts matched your criteria.

Discovering new materials for biomedical devices

Understanding the unique properties of a new class of smart materials for developing miniaturized biomedical systems

Innovative methodologies for device manufacturing

Controlling materials’ features and identifying the most suitable techniques for producing biomedical devices

Demonstration in real medical applications

Integration in Micro-Electro-Mechanical Systems (MEMS), thus enabling smart devices with diagnostic, prognostic and therapeutic functions


Bio-compatible electrostrictive smart materials for future generation of medical micro-electro- mechanical systems (MEMS)

BioWings is a project funded by the European Commission in the Horizon 2020 framework, under the Future Emerging Technologies (FET) Open programme. It is a Research Innovation Action (RIA) aligned with the key goal of the FET programme: supporting the early stages of science and technology research and innovation around new ideas, towards radically new future technologies.

Starting in June 2018 and for the following 48 months of activities, 7 partners will collaborate to investigate the unique properties of a completely new class of smart actuating materials and facilitate the integration in biocompatible MEMS.

The power of MEMS

Micro-Electro-Mechanical Systems (MEMS) are key components of smart biomedical systems, enabling miniaturised devices with diagnostic, prognostic and therapeutic functionalities.

Although these systems are poised to revolutionize medical diagnostics and treatment approaches, the slow progress in the development of biocompatible actuator materials used in these devices is still hindering this industry, preventing a host of new biomedical devices to enter the mainstream market.

A new generation of smart materials

BioWings’ main goal is to study, understand and implement a new class of smart actuating materials, based on highly defective cerium oxides, which recently displayed unique properties:

  • non-toxicity and environmentally friendliness, unlike the current lead-based actuators;
  • exceptionally high and still uncapped electrostrictive response under moderate electric fields, enabling low power consumption devices;
  • full compatibility with silicon-based technologies and many other substrates, including metals and polymers.

The project will bring the technology to TRL4, preparing the ground for the industrialisation of a new class of “biomedical MEMS” with increasing geometrical and functional complexity, suitable for a large variety of implantable and/or diagnostic applications.

Moreover, the results will be demonstrated in real biomedical applications: ultrasonic generation (MHz) in microprobes and blood cell sorting for bacteria separation and haematocrit level (HCT) estimation.

BioWings goals

BioWings will benefit the overall biomedical industry by pursuing the following key goals:


Substantial decrease in power consumption in active MEMS devices.


Drastic reduction of the form factor, by integrating the materials as thin films into chips.


Drastic reduction in manufacturing, thanks to fast integration with low temperature processing.


Use of nontoxic raw materials, and greener and biocompatible manufacturing processes.


Logo Piemacs